MAR 7.1 REQUEST FOR TRIAL DE NOVO (a) Service and Filing. Any aggrieved party not having waived the right to appeal may request a trial de novo in the superior court. Any request for a trial de novo ...

James Manning / PA Images / Getty Images Danish pharmaceutical giant Novo Nordisk is set to report earnings for the third quarter of 2024 on Wednesday morning. Sales of its popular weight-loss ...

This week, 60 Minutes traveled to Denmark to report on Novo Nordisk, the pharmaceutical company that's behind the popular drugs Wegovy and Ozempic. Novo Nordisk's success with these drugs has led ...

After hours: November 29 at 4:55 PM EST Loading Chart for DE ...

The most important investigation before the FTC right now is Novo Holdings’ proposed acquisition of Catalent. Some people might be expecting the FTC to abandon that investigation because of the ...

According to Reuters and CNN, Novo Nordisk announced Monday that it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market, where more than 180 ...

LONDON — Novo Nordisk said on Wednesday it was aware of reports of 10 deaths and 100 hospitalizations of people who had taken compounded copies of its weight-loss and diabetes drugs. U.S ...

Novo Nordisk, after mulling the implications of a phase 3 fail, has given up on a late-stage kidney drug acquired in a $1.3 billion deal. The Danish pharma bought the nonsteroidal ...

You can lose a lot of labor hours keeping your test data up-to-date with your production data. The best method of creating realistic test data in MySQL using de-identification is to leverage ...

Novo's new obesity therapy Wegovy is significantly expanding the obesity treatment market given its strong efficacy and is poised to remain a key drug in the market until patent expiration in 2032.